Managed Account Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $3.83M | Buy |
80,130
+9,055
| +13% | +$432K | ﹤0.01% | 1548 |
|
|
2015
Q1 | $2.82M | Buy |
71,075
+50,662
| +248% | +$2.01M | ﹤0.01% | 1692 |
|
|
2014
Q4 | $456K | Sell |
20,413
-762
| -4% | -$17K | ﹤0.01% | 2219 |
|
|
2014
Q3 | $332K | Buy |
21,175
+3,190
| +18% | +$50K | ﹤0.01% | 2246 |
|
|
2014
Q2 | $267K | Sell |
17,985
-4,122
| -19% | -$61.2K | ﹤0.01% | 2243 |
|
|
2014
Q1 | $356K | Buy |
+22,107
| New | +$356K | ﹤0.01% | 2151 |
|